The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 11, 2017
Filed:
Jun. 19, 2014
Applicant:
Nitor Therapeutics, Birmingham, AL (US);
Inventor:
Shanta Bantia, Birmingham, AL (US);
Assignee:
Nitor Therapeutics, Birmingham, AL (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/43 (2006.01); A61K 47/22 (2006.01); A61K 39/00 (2006.01); A61K 31/519 (2006.01); A61K 45/06 (2006.01); A61K 39/08 (2006.01); A61K 39/39 (2006.01); A61K 31/7064 (2006.01);
U.S. Cl.
CPC ...
A61K 47/22 (2013.01); A61K 31/519 (2013.01); A61K 39/00 (2013.01); A61K 39/08 (2013.01); A61K 39/39 (2013.01); A61K 45/06 (2013.01); A61K 31/7064 (2013.01); A61K 2039/55511 (2013.01);
Abstract
Compositions including at least one PNP inhibitor or at least one PNP inhibitor in combination with one or more agents identified as endogenous adjuvants useful for enhancing the potency of vaccine and cancer immunotherapies being administered for the prevention or treatment of infectious diseases or cancer. The compositions may be formulated as pharmaceutical dosage forms and components may be assembled as kits. Methods for increasing the levels of endogenous adjuvants to enhance the immunogenicity of an antigen as well as to augment the potency of vaccine and cancer immunotherapies are also disclosed.